Search by Drug Name or NDC
NDC 00065-0795-15 BSS .48; .3; .75; 3.9; 6.4; 1.7 mg/mL; mg/mL; mg/mL; mg/mL; mg/mL; mg/mL Details
BSS .48; .3; .75; 3.9; 6.4; 1.7 mg/mL; mg/mL; mg/mL; mg/mL; mg/mL; mg/mL
BSS is a OPHTHALMIC SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Alcon Laboratories, Inc.. The primary component is CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM CITRATE.
Product Information
NDC | 00065-0795 |
---|---|
Product ID | 0065-0795_6d152217-ad83-4a80-ad05-8792e6aa3240 |
Associated GPIs | 86803010002000 |
GCN Sequence Number | 053979 |
GCN Sequence Number Description | balanced salt irrig soln no.2 IRRIG SOLN INTRAOCULR |
HIC3 | Q6E |
HIC3 Description | EYE IRRIGATIONS |
GCN | 21768 |
HICL Sequence Number | 026132 |
HICL Sequence Number Description | BALANCED SALT IRRIG SOLN NO.2 |
Brand/Generic | Brand |
Proprietary Name | BSS |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | balanced salt solution |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | SOLUTION |
Route | OPHTHALMIC |
Active Ingredient Strength | .48; .3; .75; 3.9; 6.4; 1.7 |
Active Ingredient Units | mg/mL; mg/mL; mg/mL; mg/mL; mg/mL; mg/mL |
Substance Name | CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM CITRATE |
Labeler Name | Alcon Laboratories, Inc. |
Pharmaceutical Class | Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestin |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA020742 |
Listing Certified Through | 2024-12-31 |
Package
NDC 00065-0795-15 (00065079515)
NDC Package Code | 0065-0795-15 |
---|---|
Billing NDC | 00065079515 |
Package | 15 mL in 1 BOTTLE (0065-0795-15) |
Marketing Start Date | 1969-03-28 |
NDC Exclude Flag | N |
Pricing Information | N/A |